Endoscopic Full Thickness Resection for Gastric GIST

Clinical Trial Description

To evaluate the clinical safety and efficacy of endoscopic full thickness resection (EFTR) for treatment of gastric GIST. A total of 30 patients will be recruited ;

Study Design

Related Conditions & MeSH terms

Gastric GIST

See also
Status	Clinical Trial	Phase
Completed	`NCT03722056` - Laparoscopic Management of Gastrointestinal Stromal Tumor of Stomach
Completed	`NCT04269941` - Prognostic Factors Affecting Survival of Gastric GIST
Not yet recruiting	`NCT04751591` - Study On Safety Of Endoscopic Resection For 2-5cm Gastric Gastrointestinal Stromal Tumor	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03722056 - Laparoscopic Management of Gastrointestinal Stromal Tumor of Stomach

Completed

NCT04269941 - Prognostic Factors Affecting Survival of Gastric GIST

Not yet recruiting

NCT04751591 - Study On Safety Of Endoscopic Resection For 2-5cm Gastric Gastrointestinal Stromal Tumor

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04198337
Study type	Interventional
Source	Chinese University of Hong Kong
Contact	Philip Wai Yan Y Chiu, MD, FRCSEd
Phone	+85235053952
Email	philipchiu@surgery.cuhk.edu.hk
Status	Recruiting
Phase	N/A
Start date	August 1, 2014
Completion date	December 31, 2024

Endoscopic Full Thickness Resection for Gastric GIST — EFTR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms